vs

Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and CAMDEN NATIONAL CORP (CAC). Click either name above to swap in a different company.

ANAPTYSBIO, INC is the larger business by last-quarter revenue ($108.2M vs $64.3M, roughly 1.7× CAMDEN NATIONAL CORP). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs 34.0%, a 11.8% gap on every dollar of revenue. Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs 22.6%).

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.

ANAB vs CAC — Head-to-Head

Bigger by revenue
ANAB
ANAB
1.7× larger
ANAB
$108.2M
$64.3M
CAC
Higher net margin
ANAB
ANAB
11.8% more per $
ANAB
45.8%
34.0%
CAC
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
22.6%
CAC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ANAB
ANAB
CAC
CAC
Revenue
$108.2M
$64.3M
Net Profit
$49.6M
$21.9M
Gross Margin
Operating Margin
61.8%
Net Margin
45.8%
34.0%
Revenue YoY
151.1%
Net Profit YoY
327.8%
EPS (diluted)
$1.64
$1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANAB
ANAB
CAC
CAC
Q1 26
$64.3M
Q4 25
$108.2M
$68.1M
Q3 25
$76.3M
$65.4M
Q2 25
$22.3M
$62.3M
Q1 25
$27.8M
$60.1M
Q4 24
$43.1M
$47.6M
Q3 24
$30.0M
$45.0M
Q2 24
$11.0M
$42.8M
Net Profit
ANAB
ANAB
CAC
CAC
Q1 26
$21.9M
Q4 25
$49.6M
$22.6M
Q3 25
$15.1M
$21.2M
Q2 25
$-38.6M
$14.1M
Q1 25
$-39.3M
$7.3M
Q4 24
$-21.8M
$14.7M
Q3 24
$-32.9M
$13.1M
Q2 24
$-46.7M
$12.0M
Operating Margin
ANAB
ANAB
CAC
CAC
Q1 26
Q4 25
61.8%
41.5%
Q3 25
45.5%
40.5%
Q2 25
-117.5%
28.5%
Q1 25
-99.2%
10.3%
Q4 24
-22.4%
38.7%
Q3 24
-75.8%
35.2%
Q2 24
-367.5%
34.7%
Net Margin
ANAB
ANAB
CAC
CAC
Q1 26
34.0%
Q4 25
45.8%
33.1%
Q3 25
19.8%
32.4%
Q2 25
-173.5%
22.6%
Q1 25
-141.6%
12.2%
Q4 24
-50.5%
30.8%
Q3 24
-109.4%
29.1%
Q2 24
-425.3%
28.0%
EPS (diluted)
ANAB
ANAB
CAC
CAC
Q1 26
$1.29
Q4 25
$1.64
$1.33
Q3 25
$0.52
$1.25
Q2 25
$-1.34
$0.83
Q1 25
$-1.28
$0.43
Q4 24
$-0.63
$1.00
Q3 24
$-1.14
$0.90
Q2 24
$-1.71
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANAB
ANAB
CAC
CAC
Cash + ST InvestmentsLiquidity on hand
$238.2M
Total DebtLower is stronger
$514.4M
Stockholders' EquityBook value
$37.2M
$710.0M
Total Assets
$364.4M
$7.0B
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANAB
ANAB
CAC
CAC
Q1 26
Q4 25
$238.2M
Q3 25
$109.8M
Q2 25
$44.3M
Q1 25
$98.6M
Q4 24
$123.1M
Q3 24
$191.6M
Q2 24
$71.8M
Total Debt
ANAB
ANAB
CAC
CAC
Q1 26
$514.4M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
ANAB
ANAB
CAC
CAC
Q1 26
$710.0M
Q4 25
$37.2M
$696.6M
Q3 25
$-29.4M
$676.4M
Q2 25
$-44.7M
$652.1M
Q1 25
$34.0M
$640.1M
Q4 24
$70.9M
$531.2M
Q3 24
$84.4M
$529.9M
Q2 24
$9.9M
$508.3M
Total Assets
ANAB
ANAB
CAC
CAC
Q1 26
$7.0B
Q4 25
$364.4M
$7.0B
Q3 25
$353.1M
$7.0B
Q2 25
$335.3M
$6.9B
Q1 25
$422.1M
$7.0B
Q4 24
$483.8M
$5.8B
Q3 24
$493.4M
$5.7B
Q2 24
$427.4M
$5.7B
Debt / Equity
ANAB
ANAB
CAC
CAC
Q1 26
0.72×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANAB
ANAB
CAC
CAC
Operating Cash FlowLast quarter
$98.0M
Free Cash FlowOCF − Capex
$98.0M
FCF MarginFCF / Revenue
90.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.98×
TTM Free Cash FlowTrailing 4 quarters
$19.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANAB
ANAB
CAC
CAC
Q1 26
Q4 25
$98.0M
$63.9M
Q3 25
$-27.4M
$36.1M
Q2 25
$-40.2M
$6.0M
Q1 25
$-10.7M
$1.0M
Q4 24
$-66.7M
$60.9M
Q3 24
$-10.1M
$-14.5M
Q2 24
$-21.3M
$14.5M
Free Cash Flow
ANAB
ANAB
CAC
CAC
Q1 26
Q4 25
$98.0M
$58.2M
Q3 25
$-27.4M
$35.4M
Q2 25
$-40.3M
$4.5M
Q1 25
$-10.7M
$-727.0K
Q4 24
$-66.9M
$55.4M
Q3 24
$-10.1M
$-16.2M
Q2 24
$-21.4M
$13.2M
FCF Margin
ANAB
ANAB
CAC
CAC
Q1 26
Q4 25
90.5%
85.5%
Q3 25
-35.9%
54.1%
Q2 25
-180.9%
7.3%
Q1 25
-38.7%
-1.2%
Q4 24
-155.3%
116.4%
Q3 24
-33.7%
-36.0%
Q2 24
-194.6%
30.8%
Capex Intensity
ANAB
ANAB
CAC
CAC
Q1 26
Q4 25
0.0%
8.4%
Q3 25
0.0%
1.1%
Q2 25
0.2%
2.4%
Q1 25
0.1%
2.9%
Q4 24
0.6%
11.7%
Q3 24
0.1%
3.8%
Q2 24
0.3%
3.0%
Cash Conversion
ANAB
ANAB
CAC
CAC
Q1 26
Q4 25
1.98×
2.83×
Q3 25
-1.81×
1.70×
Q2 25
0.43×
Q1 25
0.14×
Q4 24
4.15×
Q3 24
-1.11×
Q2 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANAB
ANAB

Segment breakdown not available.

CAC
CAC

Net Interest Income$52.4M81%
Noninterest Income$12.0M19%

Related Comparisons